Investment analysts at Stifel Nicolaus assumed coverage on shares of Life360 (NASDAQ:LIF – Get Free Report) in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm set a “buy” rating and a $37.00 price target on the stock. Stifel Nicolaus’ target price points to a potential upside of 16.61% from the company’s current price.
A number of other research analysts have also recently commented on the stock. JMP Securities started coverage on shares of Life360 in a report on Thursday, June 20th. They issued an “outperform” rating and a $38.00 target price for the company. Loop Capital raised shares of Life360 to a “strong-buy” rating and set a $36.00 price objective for the company in a research note on Monday, June 17th. Canaccord Genuity Group started coverage on shares of Life360 in a research note on Monday, June 17th. They set a “buy” rating and a $40.00 target price on the stock. UBS Group upgraded shares of Life360 to a “hold” rating and set a $32.00 price target for the company in a report on Monday, June 17th. Finally, Canaccord Genuity Group raised Life360 to a “strong-buy” rating in a report on Monday, June 17th. One research analyst has rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $37.14.
Check Out Our Latest Analysis on LIF
Life360 Stock Performance
About Life360
Life360 Inc is a family connection and safety company. Its business category includes mobile app and Tile tracking devices with a range of services, including location sharing, safe driver reports and crash detection with emergency dispatch. Life360 Inc is based in SAN FRANCISCO.
Further Reading
- Five stocks we like better than Life360
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Snowflake Stock Rebounds, Flies Higher on AI Spending
- How is Compound Interest Calculated?
- Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks
- 5 Top Rated Dividend Stocks to Consider
- Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Receive News & Ratings for Life360 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life360 and related companies with MarketBeat.com's FREE daily email newsletter.